Structure-activity relationship studies of curcumin analogues

Area of Science:

• Medicinal Chemistry
• Oncology
• Pharmacology

Background:

• Curcumin, a natural compound, exhibits anti-cancer properties but has limitations.
• Development of novel curcumin analogues is crucial for enhanced therapeutic efficacy.

Purpose of the Study:

• To synthesize and evaluate novel curcumin analogues for anti-cancer activity.
• To identify potent compounds against prostate and breast cancer cell lines.

Main Methods:

• Synthesis of twenty-four curcumin analogues in two distinct series.
• In vitro evaluation of growth inhibitory activities using IC(50) values.
• Comparative analysis of analogue potency against the parent curcumin compound.

Main Results:

• Compound 23 demonstrated significant growth inhibitory activity against both prostate and breast cancer cell lines.
• Compound 23 exhibited sub-micromolar IC(50) values, indicating high potency.
• The most potent analogue, compound 23, was approximately fifty times more potent than curcumin.

Conclusions:

• Curcumin analogues represent a promising class of compounds for cancer therapy.
• Compound 23 shows potential as a lead candidate for developing new anti-tumor drugs for breast and prostate cancers.